SIETES :: 93131 citas

Resultados de la búsqueda por ANTIPSICÓTICOS REFINAR BÚSQUEDA

1.

Gerhard T, Stroup TS, Correll CU, Setoguchi S, Strom BL, Huang C, Tan Z, Crystal S, Olfson M. Mortality risk of antipsychotic augmentation for adult depression. PLoS One 2020:30 de septiembre. [Ref.ID 103735]

2.

Tisdale JE, Chung MK, Campbell KB, Hammadah M, Joglar JA, Rajagopalan B, On behalf of the American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing. Drug-induced arrhythmias. A scientific statement from the American Heart Association. Circulation 2020;142:16 de septiembre. [Ref.ID 103712]

3.

Hart LA, Phelan EA, Yi JY, Marcum ZA, Gray SL. Use of fall eisk-increasing drugs around a fall-related injury in older adults: a systematic review. J Am Geriatr Soc 2020;68:junio. [Ref.ID 103662]

4.

Cosci F, Chouinard G. Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications. Psychother Psychosom 2020;7:abril. [Ref.ID 103647]

5.

Koblan KS, Kent J, Hopkins SC, Krystal JH, Cheng H, Goldman R, Loebel A. A non–D2-receptor-binding drug for the treatment of schizophrenia. N Engl J Med 2020;382:1497-506. [Ref.ID 103592]

6.

Just KS, Dormann H, Böhme M, Schurig M, Schneider KL, Steffens M, Dunow S, Plank-Kiegele B, Ettrich K, Seufferlein T, Gräff I, Igel S, Schricker S, Jaeger SU, Schwab MStingl J. Personalising drug safety—results from the multi-centre prospective observational study on Adverse Drug Reactions in Emergency Departments (ADRED). Eur J Clin Pharmacol 2020;76:marzo. [Ref.ID 103531]

7.

Sys J, Van Cleynenbreugel S, Deschodt M, Van der Linden L, Tournoy J. Efficacy and safety of non-benzodiazepine and non-Z-drug hypnotic medication for insomnia in older people: a systematic literature review. Eur J Clin Pharmacol 2020;76:marzo. [Ref.ID 103530]

8.

Masuda T, Misawa F, Takase M, Kane JM, Correll CU. Association with hospitalization and all-cause discontinuation among patients with schizophrenia on clozapine vs other oral second-generation antipsychotics. A systematic review and meta-analysis of cohort studies. JAMA Psychiatry 2019;76:31 de julio. [Ref.ID 103245]

9.

Oh ES, Needham DM, Nilooie R, Wilson LM, Zhang A, Robinson KA, Neufeld KJ. Antipsychotics for preventing delirium in hospitalized adults: a systematic review. Ann Intern Med 2019;171:1 de octubre. [Ref.ID 103244]

10.

Garcia P, Lafaurie M. Le priapisme, un effet indésirable des neuroleptiques à ne pas méconnaître. BIP Occitanie 2019;26:76. [Ref.ID 103241]

11.

Pinzani V, Ladhari C. Jeux pathologiques : pas seulement les agonistes dopaminergiques !. BIP Occitanie 2019;26:octubre. [Ref.ID 103198]

12.

Taylor P. J&J hit by $8bn judgment for man claiming breast growth due to Risperdal. PMLiVE 2019:9 de octubre. [Ref.ID 103192]

13.

Piovani D, Clavenna A, Bonati M. Prescription prevalence of psychotropic drugs in children and adolescents: an analysis of international data. Eur J Clin Pharmacol 2019;75:octubre. [Ref.ID 103184]

14.

Young K. No evidence haloperidol helps in hospital delirium. Journal Watch 2019:3 de septiembre. [Ref.ID 103168]

15.

Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia. A nested case-control study. JAMA Intern Med 2019;179:agosto. [Ref.ID 103160]

16.

Schiek S, Hildebrandt K, Zube O, Bertsche T. Fall-risk-increasing adverse reactions - is there value in easily accessible drug information? A case-control study. Eur J Clin Pharmacol 2019;75:junio. [Ref.ID 103137]

17.

Slee A, Nazareth I, Bondaronek P, Liu Y, Chenq Z, Freemantle N. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet 2019;393:23 de febrero. [Ref.ID 103110]

18.

Anónimo. Towards better patient care: drugs to avoid in 2019. Prescrire Int 2019;39:abril. [Ref.ID 103075]

19.

Attia E, Steinglass JE, Walsh BT, Wang Y, Wu P, Schreyer C, Wildes J, Yilmaz Z, Guarda AS, Kaplan AS, Marcus MD. Olanzapine versus placebo in adult outpatients with anorexia nervosa: a randomized clinical trial. Am J Psychiatry 2019:18 de enero. [Ref.ID 103015]

20.

Ray WA, Stein CM, Murray KT, Fuchs DC, Patrick SW, Daugherty J, Hall K, Cooper WO. Association of antipsychotic treatment with risk of unexpected death among children and youths. JAMA Psychiatry 2018:12 de diciembre. [Ref.ID 102895]